Next Article in Journal
Dual Function of Glucosamine in Gelatin/Hyaluronic Acid Cryogel to Modulate Scaffold Mechanical Properties and to Maintain Chondrogenic Phenotype for Cartilage Tissue Engineering
Next Article in Special Issue
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions
Previous Article in Journal
Microarray Expression Profiling of Long Non-Coding RNAs Involved in Nasopharyngeal Carcinoma Metastasis
Previous Article in Special Issue
Early Antipsychotic Treatment in Juvenile Rats Elicits Long-Term Alterations to the Dopamine Neurotransmitter System
Review

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology

1
Neurobiological Psychiatry Unit, McGill University, Montreal, QC H3A 1A1, Canada
2
Division of Neuroscience, San Raffaele Scientific Institute and Vita-Salute University, 20132 Milan, Italy
*
Author to whom correspondence should be addressed.
Academic Editor: Domenico De Berardis
Int. J. Mol. Sci. 2016, 17(11), 1953; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17111953
Received: 31 August 2016 / Revised: 25 October 2016 / Accepted: 14 November 2016 / Published: 23 November 2016
(This article belongs to the Special Issue Antipsychotics)
d-Lysergic Acid Diethylamide (LSD) is known for its hallucinogenic properties and psychotic-like symptoms, especially at high doses. It is indeed used as a pharmacological model of psychosis in preclinical research. The goal of this review was to understand the mechanism of action of psychotic-like effects of LSD. We searched Pubmed, Web of Science, Scopus, Google Scholar and articles’ reference lists for preclinical studies regarding the mechanism of action involved in the psychotic-like effects induced by LSD. LSD’s mechanism of action is pleiotropic, primarily mediated by the serotonergic system in the Dorsal Raphe, binding the 5-HT2A receptor as a partial agonist and 5-HT1A as an agonist. LSD also modulates the Ventral Tegmental Area, at higher doses, by stimulating dopamine D2, Trace Amine Associate receptor 1 (TAAR1) and 5-HT2A. More studies clarifying the mechanism of action of the psychotic-like symptoms or psychosis induced by LSD in humans are needed. LSD’s effects are mediated by a pleiotropic mechanism involving serotonergic, dopaminergic, and glutamatergic neurotransmission. Thus, the LSD-induced psychosis is a useful model to test the therapeutic efficacy of potential novel antipsychotic drugs, particularly drugs with dual serotonergic and dopaminergic (DA) mechanism or acting on TAAR1 receptors. View Full-Text
Keywords: LSD; psychosis; serotonin; dopamine; TAAR1; hallucinogens; atypical antipsychotics LSD; psychosis; serotonin; dopamine; TAAR1; hallucinogens; atypical antipsychotics
Show Figures

Graphical abstract

MDPI and ACS Style

De Gregorio, D.; Comai, S.; Posa, L.; Gobbi, G. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology. Int. J. Mol. Sci. 2016, 17, 1953. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17111953

AMA Style

De Gregorio D, Comai S, Posa L, Gobbi G. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology. International Journal of Molecular Sciences. 2016; 17(11):1953. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17111953

Chicago/Turabian Style

De Gregorio, Danilo, Stefano Comai, Luca Posa, and Gabriella Gobbi. 2016. "d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology" International Journal of Molecular Sciences 17, no. 11: 1953. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17111953

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop